179 related articles for article (PubMed ID: 34366325)
1. Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion.
Zhu LR; Yuan RX; Xia XB; Wang Y; Zhu YM; Fi L; Li J
Cancer Biomark; 2022; 33(1):71-82. PubMed ID: 34366325
[TBL] [Abstract][Full Text] [Related]
2. Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion.
Bao Q; Xu Y; Ding M; Chen P
Hereditas; 2020 Feb; 157(1):6. PubMed ID: 32102688
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a machine learning model for differential diagnosis of malignant pleural effusion using routine laboratory data.
Wei TT; Zhang JF; Cheng Z; Jiang L; Li JY; Zhou L
Ther Adv Respir Dis; 2023; 17():17534666231208632. PubMed ID: 37941347
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study.
Fan X; Liu Y; Liang Z; Wang S; Yang J; Wu A
Pathol Oncol Res; 2022; 28():1610280. PubMed ID: 35515016
[No Abstract] [Full Text] [Related]
6. Extracellular Vesicle MicroRNA in Malignant Pleural Effusion.
Shojaee S; Romano G; Sanchez TM; Yermakhanova G; Saviana M; Le P; Nigita G; Calore F; Guthrie R; Hess K; Kang L; Swift-Scanlan T; Graham JT; Rahman NM; Nana-Sinkam PS; Acunzo M
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421832
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion.
Shin YM; Yun J; Lee OJ; Han HS; Lim SN; An JY; Lee KH; Lee KM; Choe KH
Cancer Res Treat; 2014 Apr; 46(2):178-85. PubMed ID: 24851110
[TBL] [Abstract][Full Text] [Related]
9. Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion.
Botana-Rial M; Casado-Rey P; Leiro-Fernández V; Andrade-Olivié M; Represas-Represas C; Fernández-Villar A
Clin Lab; 2011; 57(5-6):373-8. PubMed ID: 21755828
[TBL] [Abstract][Full Text] [Related]
10. Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.
Bixby B; Vrba L; Lenka J; Oshiro MM; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA
Sci Rep; 2024 Feb; 14(1):2939. PubMed ID: 38316884
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of pleural fluid to serum carcinoembryonic antigen ratio and delta value for malignant pleural effusion: findings from two cohorts.
Jiang MP; Wen JX; Hai L; Jiang TW; Huang JH; Chen H; Wang YF; Zheng WQ; Hu ZD; Yan L
Ther Adv Respir Dis; 2023; 17():17534666231155745. PubMed ID: 36927281
[TBL] [Abstract][Full Text] [Related]
13. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
14. S100A2: A potential biomarker to differentiate malignant from tuberculous pleural effusion.
Wang T; Wang N; Zhang L; Liu Y; Thakur A
Indian J Cancer; 2021; 58(2):241-247. PubMed ID: 33402562
[TBL] [Abstract][Full Text] [Related]
15. Exosomal MicroRNA Expression Profiling in Patients with Lung Adenocarcinoma-associated Malignant Pleural Effusion.
Tamiya H; Mitani A; Saito A; Ishimori T; Saito M; Isago H; Jo T; Yamauchi Y; Tanaka G; Nagase T
Anticancer Res; 2018 Dec; 38(12):6707-6714. PubMed ID: 30504380
[TBL] [Abstract][Full Text] [Related]
16. Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion.
Zhang H; Li C; Hu F; Zhang X; Shen Y; Chen Y; Li F
Respir Res; 2020 Oct; 21(1):284. PubMed ID: 33121490
[TBL] [Abstract][Full Text] [Related]
17. Salivary microRNAs show potential as biomarkers for early diagnosis of malignant pleural effusion.
Yang Y; Ma L; Qiao X; Zhang X; Dong SF; Wu MT; Zhai K; Shi HZ
Transl Lung Cancer Res; 2020 Aug; 9(4):1247-1257. PubMed ID: 32953502
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of periostin in lung cancer-related malignant pleural effusion.
Zhang J; Zha T; Zhang N; Sun G
J Clin Lab Anal; 2022 Feb; 36(2):e24179. PubMed ID: 35152510
[TBL] [Abstract][Full Text] [Related]
19. Combined Methylation of
Zhong Q; Wang Y; Liang C; Wei F; She B
Discov Med; 2023 Oct; 35(178):845-852. PubMed ID: 37811622
[TBL] [Abstract][Full Text] [Related]
20. Combination of DNA ploidy analysis and miR-21 or miR-24 in screening malignant pleural effusion.
Liu C; Huang L; Zhang X; Yang J
Interact Cardiovasc Thorac Surg; 2018 Mar; 26(3):376-381. PubMed ID: 29069463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
